Skip to main content
Premium Trial:

Request an Annual Quote

Sue MacLeman, William Keane

Premium
Benitec has appointed CEO Sue MacLeman to its board of directors as managing director.
 
MacLeman joined Benitec late last year. Before that, she was CEO of Australian biotech firm EqiTx.
 
She holds a BS in pharmacology from the University of Queensland.
 

 
Intellect Neurosciences has appointed William Keane to its board of directors.
 
Keane, who served as CFO and corporate secretary at antisense firm Genta until 2005, is currently a consultant, Intellect said.
 
He holds an MBA from Rutgers University School of Management and a BA in microbiology from Rutgers College.

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.